Skip to content

Lifestyle Change to Prevent Diabetes Via African-American Churches

Fit Body and Soul: A Lifestyle Intervention for Diabetes Prevention Conducted Through African American Churches

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01730196
Enrollment
604
Registered
2012-11-21
Start date
2009-09-30
Completion date
2013-04-30
Last updated
2014-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Weight Loss

Brief summary

Fit Body and Soul is single-blinded, cluster- randomized trial of a faith-based adaptation of the GLB program compared with a health education intervention.

Interventions

BEHAVIORALFit Body and Soul

Sponsors

Augusta University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to 64 Years
Healthy volunteers
Yes

Inclusion criteria

* Self-described African American * BMI ≥25kg/m2 * Planning to remain within the community for 1 year * Non-diabetic

Exclusion criteria

* Fasting plasma glucose ≥ 126 mg/dl following at least an 8-hr fast or A1C≥7.0% * HIV/AIDS * Active tuberculosis * Cancer requiring treatment in past 5 years except for cancers that have been cured or in the opinion of the researchers has a good prognosis * Stroke within the past 6 months * Cirrhosis of the liver * Currently pregnant or planning pregnancy within the study period * Gastric weight-loss surgery * Weight loss \> 10% in past three months for any reason other than childbirth * Anti-diabetic medications * Prescription weight- loss medications * Anti-neoplastic agents * Anti-psychotic agents that have gluco-corticoid effect * Oral corticosteroid use \>6 weeks * Unwilling or unable to give informed consent * Unable to communicate with the church team or research group * Participation in another research study that would interfere with FBAS

Design outcomes

Primary

MeasureTime frame
Weight change12-weeks post intervention

Secondary

MeasureTime frameDescription
Fasting plasma glucose12 week post intervention
physical activity level12 week post-intervention
cost-effectiveness12 week post-intervetnionHealth Related Quality of Life (HRQoL) which will be assessed using the EQ-5D and the SF-12v2®
hemoglobin A1C12 week intervention
quality of life measures12 week post-intervention

Other

MeasureTime frame
waist circumference12 weeks post-intervention

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 14, 2026